Font Size:
a
A
A
Keyword [Advers e Reactions]
Result: 1 - 1 | Page: 1 of 1
1.
Efficacy Of Switching To Nilotinib Among Patients Failed To Achieve A BCR-ABL Transcript Level ≤10% After 6 Months After Imatinib Initiation
<<First
<Prev Next>
Last>>
Jump to
